Literature DB >> 18414036

IAPs: more than just inhibitors of apoptosis proteins.

Laurence Dubrez-Daloz1, Alban Dupoux, Jessy Cartier.   

Abstract

Inhibitors of apoptosis proteins (IAPs) are a conserved family of proteins identified in species ranging from virus, yeasts, nematodes, fishes, flies and mammals. The common structural feature is the presence of at least one Baculovirus IAP Repeat (BIR) domain. Hence, IAPs are also known as BIR-containing proteins (BIRCs). Most of them display anti-apoptotic properties when overexpressed. In drosophila, IAPs are sufficient and necessary to promote cell survival through a direct regulation of apoptotic proteases called caspases. In mammals, BIRC4/XIAP, the most studied IAP member can directly inhibit the activity of caspase-3, 7 and 9. However, this activity is not conserved in other IAPs and physiological relevancies of such anti-caspase activities are still discussed. A detailed analysis of IAP-deficient mice or derived cells, deletion experiments performed in drosophila and zebrafish, or research of protein partners have revealed the importance of IAPs in adaptive response to cellular stress, in cell proliferation, differentiation, signaling, motility and in immune response. This review discusses recent data that help understanding of cellular functions of IAPs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414036     DOI: 10.4161/cc.7.8.5783

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  79 in total

1.  Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.

Authors:  Kozue Sakao; Sudhakar Desineni; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

2.  Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

3.  Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.

Authors:  Benigno C Valdez; Yago Nieto; David Murray; Yang Li; Guiyun Wang; Richard E Champlin; Borje S Andersson
Journal:  Exp Hematol       Date:  2012-06-09       Impact factor: 3.084

Review 4.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

5.  Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.

Authors:  Ke Wang; Jie Zhang; Jingyi Liu; Jue Tian; Ye Wu; Xiaoliang Wang; Lin Quan; Haibo Xu; Wen Wang; Huirong Liu
Journal:  Age (Dordr)       Date:  2012-04-26

6.  Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer.

Authors:  Sanjeev Shukla; Pingfu Fu; Sanjay Gupta
Journal:  Apoptosis       Date:  2014-05       Impact factor: 4.677

7.  Expression of survivin does not appear to influence breast cancer recurrence risk.

Authors:  Lindsay J Collin; Deirdre P Cronin-Fenton; Thomas P Ahern; Kristina B Christensen; Per Damkier; Stephen Hamilton-Dutoit; Anders Kjaersgaard; Kristina L Lauridsen; Rami Yacoub; Peer Christiansen; Henrik Toft Sørensen; Timothy L Lash
Journal:  Acta Oncol       Date:  2018-10-23       Impact factor: 4.089

8.  Phosphorylation of eIF2α at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency.

Authors:  Hala Muaddi; Mithu Majumder; Philippos Peidis; Andreas I Papadakis; Martin Holcik; Donalyn Scheuner; Randal J Kaufman; Maria Hatzoglou; Antonis E Koromilas
Journal:  Mol Biol Cell       Date:  2010-07-21       Impact factor: 4.138

9.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

10.  Stabilization of XIAP mRNA through the RNA binding protein HuR regulated by cellular polyamines.

Authors:  Xian Zhang; Tongtong Zou; Jaladanki N Rao; Lan Liu; Lan Xiao; Peng-Yuan Wang; Yu-Hong Cui; Myriam Gorospe; Jian-Ying Wang
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.